MAKO Surgical originally filed to come public back in September 2007. It filed to sell up to $86.25 million in securities. Recently it had indicated a price range of $14 to $16 per share for a 5.1 million share IPO. Apparently market conditions won’t support anywhere close to that.
The new price target range for this IPO is $10 to $11 per share for this IPO. The company makes advanced devices for minimally invasive knee surgeries. It is also a revenue generating company, and frankly is in a sector that should have supported a normal IPO.
We still show that JPMorgan, Morgan Stanley, Cowen & Co. and Wachovia are the underwriters for this and the ticker will still be "MAKO" on NASDAQ.
If you have followed our IPO index here internally you will note how many withdrawals have happened in IPO’s of late.
Jon C. Ogg
February 14, 2008
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
